Moonshot AI wants a $30bn valuation six months after being worth $4bn. That tells you everything about China’s AI…

TL;DR

Moonshot AI is seeking a $30bn valuation in its third funding round in six months, up from $4bn in December. The Kimi developer’s ARR topped $200m in April as Chinese AI labs race to match American peers before IPO windows open.

Moonshot AI, the Beijing-based developer of the Kimi chatbot, is seeking as much as $2 billion in a new funding round that would value the company at $30 billion, Bloomberg reported on Sunday. If the round closes at that target, it would mark a seven-fold increase in capitalisation since December, when the startup was valued at just over $4 billion.

The discussions have begun while Moonshot is still closing a previous round led by Meituan that valued it at $20 billion. That makes this the company’s third financing in six months. Total fundraising over that period: approximately $3.9 billion.

Where Moonshot sits in the pecking order

China’s AI startup hierarchy is crystallising fast. DeepSeek is raising roughly $7 billion in its debut funding round at a valuation of up to $59 billion. Zhipu AI commands approximately $80 billion. Publicly listed MiniMax, which recently doubled its sales, trades at about $20 billion in Hong Kong and is eyeing a Shanghai listing.

The 💜 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol' founder Boris, and some questionable AI art. It's free, every week, in your inbox. Sign up now!

Moonshot at $30 billion would slot in behind DeepSeek and Zhipu but ahead of MiniMax, cementing a four-company front rank in Chinese AI that collectively seeks valuations exceeding $180 billion. The gap with American peers is still large, OpenAI is valued above $850 billion and Anthropic at around $965 billion, but it is closing faster than most observers expected a year ago.

The business underneath

Unlike DeepSeek, which has emphasised research output and open-source releases, Moonshot has focused on consumer product and commercial revenue. Its annual recurring revenue topped $200 million in April, roughly doubling from $100 million at the start of March. The company sells tiered subscription plans for the Kimi chatbot and offers its underlying technology to enterprise clients.

Kimi itself has evolved rapidly. The K2 model, released in July 2025 with one trillion total parameters, was followed by the multimodal K2.5 in January 2026. The K2.6 series currently ranks as the second most-used large language model on OpenRouter. This month, Moonshot launched Kimi Work, a general-purpose AI agent built on the K2.6 models.

The founder, Yang Zhilin, is a former Tsinghua University professor who worked at Google Brain and Meta before co-founding Moonshot in March 2023 with Tsinghua alumni who were his university bandmates. The company is named after Pink Floyd’s The Dark Side of the Moon.

The IPO track

Moonshot is dismantling its offshore VIE structure to clear the path for an initial public offering in Hong Kong, after Beijing tightened its grip on overseas listings. The restructuring will not affect access to US dollar-denominated funds, as the company plans a joint-venture structure that allows foreign investors to participate.

The push towards public markets is a pattern across Chinese AI. MiniMax is already listed. DeepSeek’s debut round is backed by state vehicle China Integrated Circuit Industry Investment Fund alongside Tencent and Alibaba. Beijing is simultaneously restricting US investment in its top AI firms, channelling domestic and allied capital into the sector while limiting foreign influence over governance.

What the pace says about the race

Three funding rounds in six months is unusual even by AI standards. The velocity reflects two pressures. First, training frontier models is expensive, and Chinese labs face the additional constraint of US export controls on advanced chips. Second, the IPO window for Chinese AI is opening, and companies want to enter public markets at the highest possible valuation, which means raising private capital quickly to establish the benchmark.

Moonshot’s trajectory, from $4 billion to a potential $30 billion in half a year, on $200 million in annual recurring revenue, implies a price-to-sales ratio of 150x. That is frothy by any standard. But in a market where DeepSeek is seeking $59 billion on undisclosed revenue and Zhipu commands $80 billion, frothy has become the baseline. The question is not whether these valuations are sustainable. It is whether the companies can grow into them before public markets get to decide.